Medtronic Launches First Free Safe-Driving Program for Teens with Diabetes in Los Angeles July 19

Medtronic, Inc. announced today that Test B4U Drive, the first-ever, free program for teens with diabetes combining advanced driver skills training with diabetes management education, will be held July 19-21 at The Forum in Los Angeles. In partnership with the Juvenile Diabetes No Limits Foundation, Medtronic will continue the program throughout the summer across the country to teach teens with diabetes that good diabetes management is a key to staying safe behind the wheel.

“Test B4U Drive was inspired by the most important part of a teen driver’s diabetes management plan – checking his or her glucose level before getting behind the wheel,” said Francine Kaufman, M.D., chief medical officer and vice president, global medical, clinical and health affairs for the Diabetes business at Medtronic. “If a teen’s glucose level is low or high, it must be treated and reach a normal range before driving. An insulin pump and continuous glucose monitor together in an integrated system, like the Medtronic Minimed Paradigm® REAL-Time RevelTM System, can help keep glucose levels in check 24 hours a day, so that fewer fluctuations occur.”

For all teens, driving is a privilege that comes with great risk – motor vehicle accidents are the leading cause of death for 15- to 20-year-olds1. Teens with diabetes face an increased risk while driving because an abnormal glucose level can impair essential driving skills like reaction time and judgment.

To help decrease this risk, Test B4U Drive will offer teens with diabetes real-world, hands-on training led by professional instructors that helps them identify and react to critical situations behind the wheel. Interactive classroom sessions will teach defensive driving techniques and share useful tips like checking glucose levels before driving, pulling over to a safe place to check again when driving long distances, taking action when glucose is too low or high, and carrying the right supplies.

“We are proud to partner with Medtronic and bring Test B4U Drive to America’s communities,” said Tom Bregmann, co-founder, Juvenile Diabetes No Limits Foundation. “We’re confident this program will help underscore that teens with diabetes can live life without limits and become safer drivers.”

Test B4U Drive is being offered to teens with diabetes at these locations in 2010:

  • July 19-21, The Forum, Los Angeles
  • July 26-28, Dick’s Sporting Goods Park, Commerce City, Colo. (Denver area)
  • August 2-4, KCI Expo Center, Kansas City, Mo.
  • August 9-11, Standard Bank Stadium, Crestwood, Ill. (Chicago area)

For more information, visit

Medtronic is committed to providing people with diabetes industry-leading therapy management support and education. A 24-hour helpline is accessible to patients seven days a week, 365 days a year. In addition, Medtronic in-field guidance and support as well as online interactive training provides patients with the information and tools they can use to help successfully manage their diabetes.

About the Diabetes Business at Medtronic
The Diabetes business at Medtronic ( is the world leader in advanced diabetes management solutions, including integrated diabetes management systems, insulin pump therapy, continuous glucose monitoring systems and therapy management software, as well as world-class, 24/7 expert consumer and professional service and support.

About The Juvenile Diabetes No Limits Foundation
The mission of Juvenile Diabetes No Limits Foundation ( is to provide motivation and support for the pursuit of active and exceptional lifestyles by individuals with diabetes. The foundation is a new voice helping kids, teens and young adults with juvenile diabetes realize it is possible to achieve their dreams by breaking down self-imposed limitations.

About Medtronic
Medtronic, Inc. (, headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health and extending life for millions of people around the world.

* * *


Medtronic press release

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload CAPTCHA.